fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study finds regular aspirin use associated with greatest reduction in colorectal cancer among those most at risk

Written by | 4 Aug 2024

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study led by researchers at Mass… read more.

Study shows daylight saving time has minimal effect on heart health

Written by | 1 Mar 2024

A recent Mayo Clinic study examining the effects of daylight saving time (DST) on heart health suggests that the impact is likely minimal. In the nationwide study, researchers applied an… read more.

Both virtual and in-person nutrition visits help to lower cholesterol, study finds

Written by | 13 Dec 2023

Despite an end to the national public health emergency in May 2023, the use of telehealth remains high, with over 20% of American adults taking appointments online. These visits include… read more.

Vitamin D supplements may reduce risk of serious cardiovascular events in older people

Written by | 13 Jul 2023

Vitamin D supplements may reduce the risk of major cardiovascular events such as heart attacks among people aged over 60, finds a clinical trial published by The BMJ today. The… read more.

Two drugs are the same in preventing major cardiovascular events in hypertension

Written by | 31 Dec 2022

Investigators from a large USA Veterans Administration study report that chlorthalidone and hydrochlorothiazide are equally effective in preventing major cardiovascular events in patients with hypertension. The findings were… read more.

How have changes in anemia care affected patients with kidney failure

Written by | 23 May 2022

A recent study published in CJASN has investigated how 2011 changes to anemia care have impacted clinical outcomes among patients with kidney failure who are receiving hemodialysis. Anemia—a shortage of… read more.

UK MHRA approves Vazkepa to reduce the risk of cardiovascular events – Amarin Corp

Written by | 27 Apr 2021

Amarin Corporation announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a Great Britain Marketing Authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.